TrialDiabetes care2009

A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatment.

John P H Wilding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.